Literature DB >> 15292069

Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell function.

Abie Craiu1, Yoriko Saito, Ana Limon, Henry M Eppich, Douglas P Olson, Neil Rodrigues, Gregor B Adams, David Dombkowski, Paul Richardson, Robert Schlossman, Peter S Choi, Jonathan Grogins, Paula G O'Connor, Kenneth Cohen, Eyal C Attar, Jay Freshman, Rebecca Rich, Joseph A Mangano, John G Gribben, Kenneth C Anderson, David T Scadden.   

Abstract

Autologous stem cell transplantation, in the setting of hematologic malignancies such as lymphoma, improves disease-free survival if the graft has undergone tumor purging. Here we show that flowing hematopoietic cells through pulsed electric fields (PEFs) effectively purges myeloma cells without sacrificing functional stem cells. Electric fields can induce irreversible cell membrane pores in direct relation to cell diameter, an effect we exploit in a flowing system appropriate for clinical scale. Multiple myeloma (MM) cell lines admixed with human bone marrow (BM) or peripheral blood (PB) cells were passed through PEFs at 1.35 kV/cm to 1.4 kV/cm, resulting in 3- to 4-log tumor cell depletion by flow cytometry and 4.5- to 6-log depletion by tumor regrowth cultures. Samples from patients with MM gave similar results by cytometry. Stem cell engraftment into nonobese diabetic-severe combined immunodeficient (NOD/SCID)/beta2m-/- mice was unperturbed by PEFs. Flowing cells through PEFs is a promising technology for rapid tumor cell purging of clinical progenitor cell preparations.

Entities:  

Mesh:

Year:  2004        PMID: 15292069     DOI: 10.1182/blood-2003-12-4399

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Microfluidic electroporation of tumor and blood cells: observation of nucleus expansion and implications on selective analysis and purging of circulating tumor cells.

Authors:  Ning Bao; Thuc T Le; Ji-Xin Cheng; Chang Lu
Journal:  Integr Biol (Camb)       Date:  2010-01-05       Impact factor: 2.192

2.  A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants.

Authors:  A Nahimana; D Aubry; L Lagopoulos; P Greaney; A Attinger; S Demotz; K M Dawson; M Schapira; J Tschopp; M Dupuis; M A Duchosal
Journal:  Blood Cancer J       Date:  2011-12-09       Impact factor: 11.037

3.  A Flow-Through Cell Electroporation Device for Rapidly and Efficiently Transfecting Massive Amounts of Cells in vitro and ex vivo.

Authors:  Deyao Zhao; Dong Huang; Yang Li; Mengxi Wu; Wenfeng Zhong; Qiang Cheng; Xiaoxia Wang; Yidi Wu; Xiao Zhou; Zewen Wei; Zhihong Li; Zicai Liang
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379

4.  Role of stem cells in cancer therapy and cancer stem cells: a review.

Authors:  Jayesh Sagar; Boussad Chaib; Kevin Sales; Marc Winslet; Alexander Seifalian
Journal:  Cancer Cell Int       Date:  2007-06-04       Impact factor: 5.722

5.  Inactivation of Pichia rhodanensis in relation to membrane and intracellular compounds due to microchip pulsed electric field (MPEF) treatment.

Authors:  Ning Zhu; Ning Yu; Yue Zhu; Yulong Wei; Haiping Zhang; Ai-Dong Sun
Journal:  PLoS One       Date:  2018-06-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.